ArticleTranslational lung cancer research2021

Randomized phase III study comparing the first-line chemotherapy regimens in patients with driver mutation-negative advanced non-small cell lung cancer and poor performance status complicated with chronic obstructive pulmonary disease.

Guoying Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.